Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +12.67%
#3 Meteora Meteora +11.24%
#4 Glidr Glidr +9.27%
#5 OPENLOOT OPENLOOT +8.94%
#6 Unit Pump Unit Pump +8.52%
#7 Pump.fun Pump.fun +8.52%
#8 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.55%
#9 eCash eCash +7.18%
#10 Cash Cat Cash Cat +7.15%
Coin of the day
PulseChain PulseChain
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Codex DNA, Inc. Codex DNA, Inc.

Codex DNA, Inc.

DNAY
Classifica tra le azioni #28192
Operating in the synthetic biology sector, Codex DNA, Inc. develops,... Operating in the synthetic biology sector, Codex DNA, Inc. develops, manufactures, and sells advanced instruments, reagents, and complementary services. Its primary customer base comprises pharmaceutical firms and academic laboratories worldwide, though it also extends its offerings to government institutions, contract research organizations, and other synthetic biology companies. The company's innovative product portfolio includes the BioXp system, designed to transform digital DNA sequences into usable synthetic DNA, alongside the intuitive BioXp portal, an online platform facilitating DNA sequence design and assembly into chosen vectors. Researchers can also access BioXp kits, which supply essential building blocks and reagents, including the proprietary Gibson Assembly brand, for specific synthetic biology applications. Further support is provided through cloud-based scripts and specialized benchtop reagents for processing products generated by the BioXp system. Moreover, Codex DNA offers Biofoundry Services, allowing clients to commission and receive endpoint-ready BioXp products like genes, clones, cell-free amplified DNA, and variant libraries, in addition to providing short oligo ligation assembly enzymatic DNA synthesis. Established in 2011 and headquartered in San Diego, California, the company rebranded as Codex DNA, Inc. in March 2020, having previously been known as SGI-DNA, Inc.
Prezzo delle azioni
$1.30
Ultima sincronizzazione: 2023-01-03
Capitalizzazione di mercato
$27.96M
Variazione (1 giorno)
8.33%
Variazione (1 anno)
0.00%
Paese
US
Scambia Codex DNA, Inc. (DNAY)

Categoria

Healthcare
EPS per Codex DNA, Inc. (DNAY)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Codex DNA, Inc., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Codex DNA, Inc. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $3.11 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $9.73 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $3.59 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $2.48 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $1.74 -
US